161 related articles for article (PubMed ID: 37171351)
21. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy.
Fatourechi V; Bergstralh EJ; Garrity JA; Bartley GB; Beatty CW; Offord KP; Gorman CA
Mayo Clin Proc; 1994 Sep; 69(9):841-8. PubMed ID: 8065185
[TBL] [Abstract][Full Text] [Related]
22. Clinical features of Graves' ophthalmopathy in an incidence cohort.
Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
Am J Ophthalmol; 1996 Mar; 121(3):284-90. PubMed ID: 8597271
[TBL] [Abstract][Full Text] [Related]
23. Clinical features and treatment of graves ophthalmopathy in pediatric patients.
Durairaj VD; Bartley GB; Garrity JA
Ophthalmic Plast Reconstr Surg; 2006; 22(1):7-12. PubMed ID: 16418658
[TBL] [Abstract][Full Text] [Related]
24. Graves' disease in children.
Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
[TBL] [Abstract][Full Text] [Related]
25. Extraocular muscle repositioning as the last therapeutic option for a patient with a severe course of Graves' Ophthalmopathy: a case report.
Rau A; Klopfer M; Rommel N; Rau-Fornefeld M; Kolk A
BMC Ophthalmol; 2018 Feb; 18(1):56. PubMed ID: 29482520
[TBL] [Abstract][Full Text] [Related]
26. Graves' ophthalmopathy--a clinical review.
Carter JN
Aust N Z J Ophthalmol; 1990 Aug; 18(3):239-42. PubMed ID: 2261168
[TBL] [Abstract][Full Text] [Related]
27. Pretibial myxedema without ophthalmopathy: an initial presentation of Graves' disease.
Lohiya S; Lohiya V; Stahl EJ
Am J Med Sci; 2013 Jul; 346(1):73-5. PubMed ID: 23514670
[TBL] [Abstract][Full Text] [Related]
28. Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism.
Le Moli R; Malandrino P; Russo M; Lo Giudice F; Frasca F; Belfiore A; Vigneri R
Front Endocrinol (Lausanne); 2020; 11():367. PubMed ID: 32595602
[No Abstract] [Full Text] [Related]
29. Serum levels of soluble Fas in patients with Graves' ophthalmopathy.
Ohtsuka K; Hashimoto M
Br J Ophthalmol; 2000 Jan; 84(1):103-6. PubMed ID: 10611108
[TBL] [Abstract][Full Text] [Related]
30. How Effective is Superolateral Orbital Decompression in Cases of Drug-Resistant Graves' Ophthalmopathy.
Shamov T; Eftimov T; Krasimirov G
Folia Med (Plovdiv); 2020 Sep; 62(3):462-467. PubMed ID: 33009740
[TBL] [Abstract][Full Text] [Related]
31. Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy.
Elbers L; Mourits M; Wiersinga W
Thyroid; 2011 Mar; 21(3):279-83. PubMed ID: 21190446
[TBL] [Abstract][Full Text] [Related]
32. Pediatric Thyroid Eye Disease: Clinical Characteristics and Orbital Decompression Outcomes.
Chua MR; Tomlinson LA; Binenbaum G; Katowitz WR
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S52-S55. PubMed ID: 29985836
[TBL] [Abstract][Full Text] [Related]
33. [Surgical treatment of endocrine ophthalmopathy].
Rødahl E; Seland J; Olofsson J; Aanderud S; Kråkenes J
Tidsskr Nor Laegeforen; 1999 May; 119(12):1737-42. PubMed ID: 10380588
[TBL] [Abstract][Full Text] [Related]
34. Onset of Marine-Lenhart syndrome and Graves' ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis.
Le Moli R; Russo M; Malandrino P; Vella V; Belfiore A; Frasca F
Hormones (Athens); 2021 Mar; 20(1):161-165. PubMed ID: 32500462
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of pediatric Graves' orbitopathy.
Eha J; Pitz S; Pohlenz J
Int Ophthalmol; 2010 Dec; 30(6):717-21. PubMed ID: 20191374
[TBL] [Abstract][Full Text] [Related]
36. The effects of Rituximab on Graves'orbitopathy: A retrospective study of 14 patients.
Eid L; Coste-Verdier V; Longueville E; Ribeiro E; Nicolescu-Catargi B; Korobelnik JF
Eur J Ophthalmol; 2020 Sep; 30(5):1008-1013. PubMed ID: 31025590
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
Chen DY; Chen TH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
[TBL] [Abstract][Full Text] [Related]
38. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
[TBL] [Abstract][Full Text] [Related]
39. Studies on the occurrence of ophthalmopathy in Graves' disease.
Marcocci C; Bartalena L; Bogazzi F; Panicucci M; Pinchera A
Acta Endocrinol (Copenh); 1989 Apr; 120(4):473-8. PubMed ID: 2718699
[TBL] [Abstract][Full Text] [Related]
40. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
